PD1 ANTIBODY

Clinical trials for PD1 ANTIBODY explained in plain language.

Never miss a new study

Get alerted when new PD1 ANTIBODY trials appear

Sign up with your email to follow new studies for PD1 ANTIBODY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Three-Drug attack before surgery aims to stop deadly liver Cancer's return

Disease control Ongoing

This study is testing a new three-drug combination given before surgery for a type of aggressive liver cancer called intrahepatic cholangiocarcinoma. The goal is to shrink tumors and lower the very high chance of the cancer coming back after surgery. Researchers will compare this…

Matched conditions: PD1 ANTIBODY

Phase: PHASE2, PHASE3 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control

Last updated Mar 09, 2026 14:23 UTC

PD1 ANTIBODY

Get alerted when new PD1 ANTIBODY trials appear

Three-Drug attack before surgery aims to stop deadly liver Cancer's return